Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Nuvectis Pharma Inc
NVCTCurrent price
5.73 USD
+0.64 USD (+12.57%)
Last closed
10.67 USD
Company
www.nuvectis.com
ISIN
US67080T1088
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
208 860 016 USD
Yield for 12 month
-30.12 %
1Y
3Y
5Y
10Y
15Y
NVCT
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. The company's lead product candidate is NXP800, a novel small molecule that is in Phase 1b clinical trials for the treatment of patients with platinum-resistant, ARID1a-mutated ovarian carcinoma. It is also developing NXP900, a small molecule drug candidate, which is in Phase 1a clinical trails that inhibits the Proto-oncogene c-Src and YES1 kinases. It has license agreement with the CRT Pioneer Fund for the NXP800 and any of related derivatives; and the University of Edinburgh for the NXP900 and any of associated derivatives. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey. Address: 1 Bridge Plaza, Fort Lee, NJ, United States, 07024
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
22 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
+149 000 USD
Current Quarter
–
Last Quarter
–
Current Year
-22 897 000 USD
Last Year
-19 085 000 USD
Current Quarter
-4 359 000 USD
Last Quarter
-4 643 000 USD
Key Figures NVCT
1 year
3 years
5 years
10 years
EBITDA
–
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-60.86 %
PEG Ratio
–
Return On Equity TTM
-140 %
Wall Street Target Price
22 USD
Revenue TTM
–
Book Value
0.58 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-1.16 USD
Diluted Eps TTM
-1.16 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics NVCT
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NVCT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation NVCT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-7.3803
Price Book MRQ
18.9852
Financials NVCT
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NVCT
For 52 weeks
5.85 USD
12.1 USD
50 Day MA
6.92 USD
Shares Short Prior Month
989 582
200 Day MA
7.17 USD
Short Ratio
11.5
Shares Short
1 046 818
Short Percent
11.04 %
BeatStart